Episode 21 - The Better Question: What If Midlife Symptoms Aren’t Inevitable?
This episode of The Resiliency Method® Podcast features Dr. Erika Schultz interviewing Dr. Aimee Duffy, a board-certified physician, functional medicine practitioner specializing in BHRT (bioidentical hormone replacement therapy), and president of the North Carolina Integrative Medical Society.
Dr. Duffy's origin story: She fell in love with babies as a child, became a "mother's helper" at 11, and decided to become an OB-GYN after witnessing a birth in high school. She went into family practice instead of OB-GYN and eventually became a primary care/OB physician for women, where she realized her medical training left her ill-equipped in women's hormone health.
The Women's Health Initiative controversy: Dr. Duffy explains how this ~2002 study (average patient age 65) tested Premarin (pregnant mare's urine) and PremPro (with synthetic progestin), found increased breast cancer and stroke risk, and got cut short. Media coverage broadly demonized "hormone replacement" rather than those specific synthetic, non-bioidentical drugs — leading to decades of fear and undertreatment, including a black box warning (partially lifted in October, for vaginal estrogen).
Three Key Takeaways
1. The Hormone Fear Was Built on a Flawed Study
The Women's Health Initiative used synthetic, non-bioidentical hormones (Premarin and PremPro) on an older population and found real risks—but the results were broadly misapplied to condemn all hormone replacement, leaving a generation of women undertreated and afraid.
2. Bioidentical Doesn't Just Mean the Molecule—It Means the Delivery
True BHRT should match the body's own hormone structure and mimic natural physiologic patterns. Dr. Duffy explains why she favors topical dosing over oral pills or pellets, which can cause hormone "floods and droughts" rather than steady, sustainable balance.
3. Testing Should Guide Treatment, Not Guesswork
Saliva testing reflects what's actually available to tissues and is best for dosing; urine testing (collected in multiple samples) reveals how hormones are metabolized and flags safety concerns. Blood testing alone is often the least accurate once someone starts topical hormone therapy.
Listen here:
